Image Credit: STAT News

STAT+: Sanofi to buy Blueprint Medicines in deal worth more than $9 billion

Watchdoq June 2, 2025

Sanofi plans to buy Blueprint Medicines in a deal worth more than $9 billion, expanding its immunology pipeline